Skip to Main content Skip to Navigation
Journal articles

CAR-T cells and BiTEs in solid tumors: challenges and perspectives

Abstract : Chimeric antigen receptor (CAR)-modified T cells and BiTEs are both immunotherapies which redirect T cell specificity against a tumor-specific antigen through the use of antibody fragments. They demonstrated remarkable efficacy in B cell hematologic malignancies, thus paving the way for their development in solid tumors. Nonetheless, the use of such new drugs to treat solid tumors is not straightforward. So far, the results from early phase clinical trials are not as impressive as expected but many improvements are under way. In this review we present an overview of the clinical development of CAR-T cells and BiTEs targeting the main antigens expressed by solid tumors. We emphasize the most frequent hurdles encountered by either CAR-T cells or BiTEs, or both, and summarize the strategies that have been proposed to overcome these obstacles.
Document type :
Journal articles
Complete list of metadata
Contributor : Xavier Chard-Hutchinson <>
Submitted on : Tuesday, May 18, 2021 - 12:22:34 PM
Last modification on : Friday, May 28, 2021 - 5:34:56 PM


Publisher files allowed on an open archive


Distributed under a Creative Commons Attribution 4.0 International License



Julien Edeline, Roch Houot, Aurélien Marabelle, Marion Alcantara. CAR-T cells and BiTEs in solid tumors: challenges and perspectives. Journal of Hematology and Oncology, BioMed Central, 2021, 14 (1), pp.65. ⟨10.1186/s13045-021-01067-5⟩. ⟨hal-03228682⟩



Record views


Files downloads